2-[(3-methylphenoxy)methyl]-5-[[1-[4-(trifluoromethyl)phenyl]tetrazol-5-yl]methylsulfanyl]-1,3,4-oxadiazole
C19H15F3N6O2S — CID 52691221
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(3-methylphenoxy)methyl]-5-[[1-[4-(trifluoromethyl)phenyl]tetrazol-5-yl]methylsulfanyl]-1,3,4-oxadiazole
2-[(3-methylphenoxy)methyl]-5-[[1-[4-(trifluoromethyl)phenyl]tetrazol-5-yl]methylsulfanyl]-1,3,4-oxadiazole (PubChem CID 52691221) has the molecular formula C19H15F3N6O2S and a molecular weight of 448.43 g/mol. Its IUPAC name is 2-[(3-methylphenoxy)methyl]-5-[[1-[4-(trifluoromethyl)phenyl]tetrazol-5-yl]methylsulfanyl]-1,3,4-oxadiazole.
Molecular Properties
| Compound Name | 2-[(3-methylphenoxy)methyl]-5-[[1-[4-(trifluoromethyl)phenyl]tetrazol-5-yl]methylsulfanyl]-1,3,4-oxadiazole |
|---|---|
| PubChem CID | 52691221 |
| Molecular Formula | C19H15F3N6O2S |
| Molecular Weight | 448.43 g/mol |
| Exact Mass | 448.09 |
| IUPAC Name | 2-[(3-methylphenoxy)methyl]-5-[[1-[4-(trifluoromethyl)phenyl]tetrazol-5-yl]methylsulfanyl]-1,3,4-oxadiazole |
| SMILES | Cc1cccc(OCc2nnc(SCc3nnnn3-c3ccc(C(F)(F)F)cc3)o2)c1 |
| InChI | InChI=1S/C19H15F3N6O2S/c1-12-3-2-4-15(9-12)29-10-17-24-25-18(30-17)31-11-16-23-26-27-28(16)14-7-5-13(6-8-14)19(20,21)22/h2-9H,10-11H2,1H3 |
| InChIKey | PWZYTGDSQPOGDH-UHFFFAOYSA-N |
| XLogP | 4.24 |
| TPSA | 91.75 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 448.43 |
| LogP ≤ 5 | 4.24 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 52691221 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.